Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines. Intravenous magnesium sulphate, salbutamol and aminophylline all have advocates but what order, speed of delivery or dosage is left up to the individual physician treating the patient. A child in respiratory failure was given a large, fast dose of intravenous magnesium sulphate before intravenous salbutamol which relaxed bronchial smooth muscle immediately and tracheal intubation and lung ventilation was avoided. Justification for this treatment is discussed
BACKGROUND: Magnesium sulphate, administered by the intravenous (i.v.) or inhaled (nebulised) route,...
Background Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...
Background: Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...
Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines...
Background: Previous studies suggested intravenous or nebulised magnesium sulphate (MgSO 4 ) might i...
Background: A recent meta-analysis showed that intravenous and nebulised magnesium sulphate have sim...
What is the most appropriate second-line intravenous bronchodilator treatment when a child with a se...
Objectives: To describe the role of intravenous magnesium sulfate (MgSO4) as therapy for acute sever...
 Objective: To compare the outcome of addition of nebulized magnesium sulphate to the standard tre...
SummaryBackgroundTreatment of acute asthma is based on rapid reversal of bronchospasm and airway inf...
Nebulization with B-agonist and administration of systemic corticosteroids are standard treatments f...
Objective: The outcomes were mostly debatable; consequently researchers led the current investigatio...
Objective: Continued enthusiasm for intravenous magnesium sulfate to use it in many different signs ...
Background Intravenous magnesium can cause bronchodilation in treatment of severe asthma, however it...
BACKGROUND: Asthma is the most common pediatric chronic disease and currently affects 7.1 million ch...
BACKGROUND: Magnesium sulphate, administered by the intravenous (i.v.) or inhaled (nebulised) route,...
Background Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...
Background: Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...
Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines...
Background: Previous studies suggested intravenous or nebulised magnesium sulphate (MgSO 4 ) might i...
Background: A recent meta-analysis showed that intravenous and nebulised magnesium sulphate have sim...
What is the most appropriate second-line intravenous bronchodilator treatment when a child with a se...
Objectives: To describe the role of intravenous magnesium sulfate (MgSO4) as therapy for acute sever...
 Objective: To compare the outcome of addition of nebulized magnesium sulphate to the standard tre...
SummaryBackgroundTreatment of acute asthma is based on rapid reversal of bronchospasm and airway inf...
Nebulization with B-agonist and administration of systemic corticosteroids are standard treatments f...
Objective: The outcomes were mostly debatable; consequently researchers led the current investigatio...
Objective: Continued enthusiasm for intravenous magnesium sulfate to use it in many different signs ...
Background Intravenous magnesium can cause bronchodilation in treatment of severe asthma, however it...
BACKGROUND: Asthma is the most common pediatric chronic disease and currently affects 7.1 million ch...
BACKGROUND: Magnesium sulphate, administered by the intravenous (i.v.) or inhaled (nebulised) route,...
Background Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...
Background: Little evidence is available for the effect of nebulised magnesium sulphate (MgSO4) in a...